United States Biotechnology Industry - Porter’s Five Forces Strategy Analysis
The rapidly evolving biotechnology industry is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes that are relieving human suffering, improving health, and increasing the quality of life for the world’s citizens. The majority of U.S. biotechnology firms are pursuing markets in human health care.
Aruvian's Research analyzes the US Biotechnology industry in the Michael Porter’s Five Forces Analysis. It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market.
Apart from the Porter’s Five Forces analysis, the report also analyzes the biotechnology industry in the US in a brief profile.